查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1234352

放射性免疫测定法的全球市场-成长，未来展望，竞争分析(2023年～2031年)

Radioimmunoassay Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

检测血液中小分子的医学研究以及放射免疫分析技术在癌症、传染病和过敏性疾病临床诊断中的应用推动市场的成长。此外，医学研究的快速发展和医学领域研发支出增加也推动市场成长。

本报告提供全球放射性免疫测定法市场相关调查分析，市场动态，市场分析，企业简介等系统性资讯。

目录

第1章 序文

  • 报告的说明
    • 报告的目的
    • 目标受众
    • 主要的产品
  • 市场区隔
  • 调查手法
    • 阶段Ⅰ-2次调查
    • 阶段Ⅱ-1次调查
    • 阶段Ⅲ-专家的审查
    • 假设
    • 所采用的方法

第2章 摘要整理

  • 市场概述:全球放射性免疫测定法市场
  • 全球放射性免疫测定法市场(100万美元)(2021年):各产品
  • 全球放射性免疫测定法市场(100万美元)(2021年):各用途
  • 全球放射性免疫测定法市场(100万美元)(2021年):各终端用户
  • 全球放射性免疫测定法市场(100万美元)(2021年):各地区
  • 富有魅力的投资提案(2021年):各地区

第3章 放射性免疫测定法市场:竞争分析

  • 主要的放射性免疫测定法市场供应商的市场定位
  • 放射性免疫测定法市场供应商采用的策略
  • 主要的产业策略
  • 阶层分析:2021年和2030年的比较

第4章 放射性免疫测定法市场:常量分析和市场动态

  • 简介
  • 全球放射性免疫测定法市场金额(100万美元)(2020年～2030年)
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 主要课题
    • 主要的机会
  • 促进因素与阻碍因素的影响分析
  • See-Saw分析

第5章 放射性免疫测定法市场，美金(100万)(2020年～2030年):各产品

  • 市场概要
  • 成长和收益分析:2021年和2030年的比较
  • 市场区隔
    • 试剂和套件
    • 分析设备

第6章 放射性免疫测定法市场，美金(100万)(2020年～2030年):各用途

  • 市场概要
  • 成长和收益分析:2021年和2030年的比较
  • 市场区隔
    • 医学研究
    • 临床诊断

第7章 放射性免疫测定法市场，美金(100万)(2020年～2030年):各终端用户

  • 市场概要
  • 成长和收益分析:2021年和2030年的比较
  • 市场区隔
    • 医院
    • 製药企业
    • 学术、研究机关
    • 医学研究所
    • 其他

第8章 北美的放射性免疫测定法市场，美金(100万)(2020年～2030年)

第9章 英国及欧洲联盟的放射性免疫测定法市场，美金(100万)(2020年～2030年)

第10章 亚太地区的放射性免疫测定法市场，美金(100万)(2020年～2030年)

第11章 南美的放射性免疫测定法市场，美金(100万)(2020年～2030年)

第12章 中东及非洲的放射性免疫测定法市场，美金(100万)(2020年～2030年)

第13章 企业简介

  • PerkinElmer Inc.
  • Beckman Coulter, Inc.
  • DIAsource ImmunoAssays SA
  • Euro Diagnostica AB
  • Merck KGaA
  • MP Biomedicals, LLC
  • DiaSorin S.p.A.
  • Berthold Technologies GmbH & Co. KG
  • DRG International, Inc.
  • STRATEC Biomedical AG
  • IBL Internationa
  • Cisbi
  • EMD Millipore
  • Izotop
Product Code: 138172-01-23

An immunoassay is a bioanalytical method used to detect or measure specific proteins or other substances through their properties as antigens or antibodies. A radioimmunoassay (RIA) is an immunoassay that uses an antigen labeled with a radioisotope and measure the subsequent radioactivity of the antibody component in order to detect the antigen-antibody complex. RIA is gaining noteworthy significance in medical diagnostics owing to its high precision, accuracy, specificity of results, and sensitivity. RIA kits are used to perform in-vitro assays/procedures whereas, radioimmunoassay analyzer is a device used to run immunoassay tests in order to detect the presence & concentration of substances in the samples.

The use of radioimmunoassay technique in medical research to find small molecules in the blood and in the clinical diagnosis of cancer, autoimmune diseases, infectious diseases, endocrine disorders, and allergic diseases are majorly driving the growth of the radioimmunoassay market. Technological advances in RIA products coupled with rising adoption of RIA in clinical laboratories, pharmaceutical industries, and research institutes are fostering the market growth rapidly. Moreover, rapid developments in medical research and increased spending in research & development in the healthcare sector to support the market growth in near future. On the contrary, the presence of alternatives to RIA such as ELISA (enzyme-linked immunosorbent assay), chemiluminescent immunoassay (CLIA), immunofluorescence assay (IFA), are anticipated to hinder the market growth over the forecast period.

The reagents & kits segment is expected to dominate the market during the forecast period owing to their limited durability and repetitive purchase or use. The clinical diagnosis segment is likely to register lucrative CAGR over the forecast period owing to worldwide rising prevalence of cancer, autoimmune diseases, infectious diseases, endocrine disorders, and allergic diseases. On the basis of end user, the medical laboratories segment is anticipated to exhibit profitable market growth over next nine years is attributed to rising demand to perform diagnostic procedures.

Europe is likely to hold a major chunk of the market due to higher adoption of radioimmunoassay technique in medical laboratories, pharmaceutical companies and research institutes coupled with flourishing pharmaceutical industries in the U.K., Germany, France, Italy, and Spain. Asia Pacific shall register fastest market growth attributed to growing geriatric population and rising incidence of cancer along with propelled demand for RAI in China and India.

Key players identified in the global radioimmunoassay market include:

PerkinElmer Inc.

Beckman Coulter, Inc.

DIAsource ImmunoAssays SA

Euro Diagnostica AB

Merck KGaA

MP Biomedicals, LLC

DiaSorin S.p.A.

Berthold Technologies GmbH & Co. KG

DRG International, Inc.

STRATEC Biomedical AG

IBL Internationa

Cisbi

EMD Millipore

Izotop

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Radioimmunoassay market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Radioimmunoassay market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Reagents & Kits

Analyzers

Application

Medical Research

Clinical Diagnosis

End User

Hospitals

Pharmaceutical Companies

Academic Research Institutes

Medical Laboratories

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Radioimmunoassay market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Radioimmunoassay market?

Which is the largest regional market for Radioimmunoassay market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Radioimmunoassay market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Radioimmunoassay market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Radioimmunoassay Market
  • 2.2. Global Radioimmunoassay Market, By Product, 2021 (US$ Million)
  • 2.3. Global Radioimmunoassay Market, By Application, 2021 (US$ Million)
  • 2.4. Global Radioimmunoassay Market, By End User, 2021 (US$ Million)
  • 2.5. Global Radioimmunoassay Market, By Geography, 2021 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2021

3. Radioimmunoassay Market: Competitive Analysis

  • 3.1. Market Positioning of Key Radioimmunoassay Market Vendors
  • 3.2. Strategies Adopted by Radioimmunoassay Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Radioimmunoassay Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Radioimmunoassay Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Reagents & Kits
    • 5.3.2. Analyzers

6. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Medical Research
    • 6.3.2. Clinical Diagnosis

7. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Pharmaceutical Companies
    • 7.3.3. Academic Research Institutes
    • 7.3.4. Medical Laboratories
    • 7.3.5. Others

8. North America Radioimmunoassay Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
  • 8.3. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
  • 8.4. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
  • 8.5.Radioimmunoassay Market: By Region, 2020-2030, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.1.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 8.5.1.1.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.2.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 8.5.1.2.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 8.5.1.3.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 8.5.1.3.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)

9. UK and European Union Radioimmunoassay Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
  • 9.3. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
  • 9.4. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
  • 9.5.Radioimmunoassay Market: By Region, 2020-2030, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.1.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 9.5.1.1.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.2.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 9.5.1.2.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.3.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 9.5.1.3.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.4.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 9.5.1.4.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.5.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 9.5.1.5.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 9.5.1.6.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 9.5.1.6.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)

10. Asia Pacific Radioimmunoassay Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
  • 10.3. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
  • 10.4. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
  • 10.5.Radioimmunoassay Market: By Region, 2020-2030, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.1.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 10.5.1.1.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.2.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 10.5.1.2.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.3.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 10.5.1.3.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.4.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 10.5.1.4.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.5.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 10.5.1.5.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 10.5.1.6.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 10.5.1.6.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)

11. Latin America Radioimmunoassay Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
  • 11.3. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
  • 11.4. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
  • 11.5.Radioimmunoassay Market: By Region, 2020-2030, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.1.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 11.5.1.1.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.2.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 11.5.1.2.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 11.5.1.3.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 11.5.1.3.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)

12. Middle East and Africa Radioimmunoassay Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
  • 12.3. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
  • 12.4. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
  • 12.5.Radioimmunoassay Market: By Region, 2020-2030, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.1.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 12.5.1.1.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.2.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 12.5.1.2.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Radioimmunoassay Market: By Product, 2020-2030, USD (Million)
        • 12.5.1.3.1. Radioimmunoassay Market: By Application, 2020-2030, USD (Million)
        • 12.5.1.3.1. Radioimmunoassay Market: By End User, 2020-2030, USD (Million)

13. Company Profile

  • 13.1.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. PerkinElmer Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Beckman Coulter, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. DIAsource ImmunoAssays SA
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Euro Diagnostica AB
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Merck KGaA
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. MP Biomedicals, LLC
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. DiaSorin S.p.A.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Berthold Technologies GmbH & Co. KG
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. DRG International, Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. STRATEC Biomedical AG
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. IBL Internationa
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Cisbi
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. EMD Millipore
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. Izotop
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 3 Global Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 4 North America Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 5 North America Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 6 North America Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 7 U.S. Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 8 U.S. Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 9 U.S. Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 10 Canada Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 11 Canada Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 12 Canada Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 19 UK Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 20 UK Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 21 UK Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 22 Germany Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 23 Germany Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 24 Germany Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 25 Spain Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 26 Spain Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 27 Spain Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 28 Italy Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 29 Italy Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 30 Italy Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 31 France Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 32 France Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 33 France Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 37 Asia Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Asia Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 39 Asia Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 40 China Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 41 China Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 42 China Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 43 Japan Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 44 Japan Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 45 Japan Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 46 India Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 47 India Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 48 India Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 49 Australia Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Australia Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 51 Australia Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 52 South Korea Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 53 South Korea Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 54 South Korea Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 55 Latin America Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 56 Latin America Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 57 Latin America Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 58 Brazil Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 59 Brazil Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 60 Brazil Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 61 Mexico Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 62 Mexico Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 63 Mexico Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 70 GCC Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 71 GCC Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 72 GCC Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 73 Africa Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 74 Africa Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 75 Africa Radioimmunoassay Market By End User, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Radioimmunoassay Market By Product, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Radioimmunoassay Market By Application, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Radioimmunoassay Market By End User, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Radioimmunoassay Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Radioimmunoassay Market: Quality Assurance
  • FIG. 5 Global Radioimmunoassay Market, By Product, 2021
  • FIG. 6 Global Radioimmunoassay Market, By Application, 2021
  • FIG. 7 Global Radioimmunoassay Market, By End User, 2021
  • FIG. 8 Global Radioimmunoassay Market, By Geography, 2021
  • FIG. 9 Market Geographical Opportunity Matrix - Global Radioimmunoassay Market, 2021
  • FIG. 10 Market Positioning of Key Radioimmunoassay Market Players, 2021
  • FIG. 11 Global Radioimmunoassay Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 12 Global Radioimmunoassay Market, By Product, 2021 Vs 2030, %
  • FIG. 13 Global Radioimmunoassay Market, By Application, 2021 Vs 2030, %
  • FIG. 14 Global Radioimmunoassay Market, By End User, 2021 Vs 2030, %
  • FIG. 15 U.S. Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 16 Canada Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 17 Rest of North America Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 18 UK Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 19 Germany Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 20 Spain Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 21 Italy Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 22 France Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 23 Rest of Europe Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 24 China Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 25 Japan Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 26 India Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 27 Australia Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 28 South Korea Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 29 Rest of Asia Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 30 Brazil Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 31 Mexico Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 32 Rest of Latin America Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 33 GCC Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 34 Africa Radioimmunoassay Market (US$ Million), 2020 - 2030
  • FIG. 35 Rest of Middle East and Africa Radioimmunoassay Market (US$ Million), 2020 - 2030